Two glasses of cherry juice a day may reduce gut inflammation in bowel disease patients, study finds
Drinking two small glasses of cherry juice a day may reduce gut inflammation and boost quality of life in bowel disease ...
'I thought my stroke was a headache but within days I couldn't walk or talk'
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
I Have Ulcerative Colitis and Used to Go to the Bathroom 20 Times a Day
Daniela Soto, 25, lives in Los Angeles and was diagnosed with ulcerative colitis (UC) when she was just 21. If you don’t know ...
Business Wire7h
Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi ® (ustekinumab-aauz)
Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...
Medscape3d
Subcutaneous Guselkumab Proves Efficacious for IBD in Two Studies: ASTRO and GRAVITI
For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
emjreviews.com3d
Microbiome Dynamics Influence Faecal Microbiota Transplantation Efficacy in Ulcerative Colitis
FAECAL microbiota transplantation (FMT) shows promise in treating ulcerative colitis (UC), with specific gut microbial ...
Contract Pharma2h
Fresenius Kabi, Formycon Launch Otulfi in US
Otulfi, an ustekinumab biosimilar for the reference product Stelara (ustekinumab), developed by Formycon AG, is now available ...
Medscape5d
New IL-7 Antagonist Lusvertikimab Shows UC Efficacy
In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...
manilatimes10d
Microbiotica unveils data on the mechanism of action of MB310, a clinical-stage drug candidate in development for the treatment of ulcerative colitis
At the ECCO meeting Dr Fernanda Schreiber, Associate Director of Translational Biology, will present 'Mechanistic understanding of MB310: a consortium of gut commensal bacteria for the treatment of ...
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union ...
OSE Immunotherapeutics Reports Full Phase 2 Induction Results for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ECCO
OSE Immunotherapeutics Reports Full Phase 2 Induction Results for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ...